Linda J. Johnston

Dr. Linda J. Johnston

Metrology Research Centre, National Research Council Canada, Ottawa, ON, Canada
orcid

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2002 in Biophysical Journal
Verified
Journal Article
Closed access
CYChunbo Yuan
Chunbo Yuan
JFJennifer Furlong
Jennifer Furlong
PBPierre Burgos
Pierre Burgos
Linda J. JohnstonLinda J. Johnston
Linda J. Johnston

13 September 2021 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
MKMelanie Kah
Melanie Kah
Linda J. JohnstonLinda J. Johnston
Linda J. Johnston
RKRai S. Kookana
Rai S. Kookana
WBWendy Bruce
Wendy Bruce
AHAndrea Haase
Andrea Haase
VGVladimir Gubala
Vladimir Gubala

12 April 2007 in Langmuir
Verified
Journal Article
Closed access
Linda J. JohnstonLinda J. Johnston
Linda J. Johnston

1 January 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AAabedelnasser abulrob
abedelnasser abulrob
ZLZhengfang Lu
Zhengfang Lu
EBEwa Baumann
Ewa Baumann
DVDusan Vobornik
Dusan Vobornik
RTRod Taylor
Rod Taylor
Linda J. JohnstonLinda J. Johnston
Linda J. Johnston
The development of some solid tumors is associated with overexpression of the epidermal growth factor receptor (EGFR) and often correlates with poor prognosis. Near field scanning optical microscopy, a technique with subdiffraction-limited optical resolution, was used to examine the influence of two inhibitors (the chimeric 225 antibody and tyrosine phosphorylation inhibitor AG1478) on the nanoscale clustering of EGFR in HeLa cells. The EGFR is organized in small clusters, average diameter of 150 nm, on the plasma membrane for both control and EGF-treated cells. The numbers of receptors in individual clusters vary from as few as one or two proteins to greater than 100. Both inhibitors yield an increased cluster density and an increase in the fraction of clusters with smaller diameters and fewer receptors. Exposure to AG1478 also decreases the fraction of EGFR that colocalizes with both rafts and caveolae. EGF stimulation results in a significant loss of the full-length EGFR from the plasma membrane with the concomitant appearance of low molecular mass proteolytic products. By contrast, AG1478 reduces the level of EGFR degradation. Changes in receptor clustering provide one mechanism for regulating EGFR signaling and are relevant to the design of strategies for therapeutic interventions based on modulating EGFR signaling.

1 July 1985 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
Linda J. JohnstonLinda J. Johnston
Linda J. Johnston
JLJ. Lusztyk
J. Lusztyk
DWD. D. M. Wayner
D. D. M. Wayner
AAA. N. Abeywickreyma
A. N. Abeywickreyma
ABA. L. J. Beckwith
A. L. J. Beckwith
KIKeith U. Ingold
Keith U. Ingold

1 May 1989 in Chemical Reviews
Verified
Journal Article
Closed access
Linda J. JohnstonLinda J. Johnston
Linda J. Johnston
JSJ. C. Scaiano
J. C. Scaiano